市場調查報告書
商品編碼
1371966
2030 年腦機介面 (BCI) 市場預測:按組件、類型、應用、最終用戶和地區分類的全球分析Brain Computer Interface Market Forecasts to 2030 - Global Analysis By Component, Type, Application, End User and By Geography. |
根據Stratistics MRC預測,2023年全球腦機介面(BCI)市場規模將達到20.7億美元,預計在預測期內將以19.5%的年複合成長率成長,到2030年達到72.3億美元。
腦機介面(BCI),又稱神經控制介面(NCI)、心機介面(MMI)、直接神經介面(DNI)、腦機介面(BMI)、腦機介面,是一種直接從大腦到外部設備的連接。實現通訊的平台。為了記錄人腦發出的電脈衝,腦機介面系統能夠執行磁振造影.整合影像方法。
根據世界衛生組織的報告,到2030年,大約有8,200萬人將受到失智症的影響,到2050年,這一數字將達到1.52億。這顯示了未來年度BCI的潛在需求。
阿茲海默症和帕金森氏症等神經退化性疾病的日益普及對腦機介面(BCI)市場產生了重大影響。這些疾病逐漸降低認知和運動功能,使其難以與環境有效溝通和互動。由於人口高齡化和診斷方法的改進,全球神經退化性疾病的盛行率持續增加,對先進腦機介面的需求不斷增加。此外,BCI 技術的創新,例如先進的訊號處理、機器學習演算法和小型化植入物,對於滿足神經退化性疾病影響的個體的特定需求至關重要,而這群患者正在推動BCI 市場的成長和發展容納增加的
腦機介面(BCI)技術的高成本是BCI市場的主要抑制因素。複雜的研發和製造流程導致成本上升。這些成本轉嫁給消費者,限制了普及和可近性,特別是對於經濟能力較差的個人而言。此外,保險往往不承保,並且可能沒有足夠的支持來實施 BCI。因此,這種最尖端科技對於許多潛在用戶來說是遙不可及的,阻礙了其更廣泛的普及並阻礙了市場的潛在成長。
醫療保健設施的快速擴張和進步為腦機介面(BCI)市場創造了巨大的機會。隨著對精準醫療和個體化醫療保健的日益關注,BCI 提供了一種創新手段來改善診斷、治療和患者照護。將腦機介面涵蓋醫療保健系統將能夠即時監測神經活動,促進各種神經系統疾病的早期發現和介入。此外,醫療機構和 BCI 開發商之間的合作允許根據特定的醫療要求客製化 BCI 解決方案。醫療保健和 BCI 之間的共生關係具有巨大的潛力,可以改變患者的治療結果,並促進 BCI 的持續發展和整合主流醫學。
缺乏熟練的專業人員對腦機介面(BCI)市場構成了重大威脅。開發和操作 BCI 需要多個領域的專業知識,包括神經科學、工程、訊號處理和機器學習。然而,這些領域的專家卻很短缺。這種短缺限制了 BCI 技術的研究、創新和有效實施的步伐。此外,腦機介面的複雜性需要專門的培訓,這使得醫療保健提供者和技術人員很難實施和最佳利用這些技術。因此,它阻礙了市場的成長。
COVID-19造成的景氣衰退對世界各地的產業產生了重大影響,但科技業受危機的影響比其他經濟領域小一些。疫情也造成經濟低迷,迫使世界各地的各類企業做出劇烈且迅速的業務變革。支援人工智慧和物聯網等最尖端科技普及的發展也有所增加。此外,在COVID-19大流行期間,已經實施腦機介面的組織能夠快速適應新病毒,因為人機接觸較少,而醫療保健領域的發展使組織能夠快速適應新病毒病毒。能夠滿足業務需求。腦機介面可以幫助企業應對當前的流行病並繼續盈利運作。
預計侵入式腦機介面領域將佔最大佔有率。這涉及將電極直接植入大腦以建立精確、高保真的神經介面。這種方法提供了無與倫比的準確性和資料解析度,使其成為神經修復和運動功能恢復等複雜應用的理想選擇。此外,隨著手術技術、材料和訊號處理演算法的進步,侵入式腦機介面領域不斷發展。該領域正在進行的研究和創新在增強侵入式腦機介面的能力和擴展其潛在應用方面具有巨大的潛力。因此,該行業的成長需求正在增加。
預計硬體產業在預測期內將出現良好成長。腦機介面 (BCI) 市場的硬體部分包括 BCI 系統有效運作所必需的實體組件。這包括電極、感測器、放大器、訊號處理設備、輸出設備等。電極在捕捉神經訊號方面發揮關鍵作用,感測器確保準確的資料收集。放大器還增強這些訊號並對其進行處理以進行分析。訊號處理單元解釋神經資料,輸出裝置傳達 BCI 系統產生的回饋和動作。此外,硬體技術、小型化和材料改進的持續進步使 BCI 更加高效、舒適和耐用,有助於 BCI 在各種應用和行業中的整體成長和採用。
在估計期間,亞太地區佔據最大的市場佔有率。由於政府資助的增加以及為尋找腦部疾病和損傷的治療方法而進行的大量研究,亞太地區的腦機介面市場正在擴大。此外,負擔得起的製造地點和有吸引力的稅收制度正在鼓勵外國公司投資亞洲國家這個利潤豐厚的產業。這大大鼓勵了腦機介面產業在該領域的拓展。此外,亞太地區腦機介面市場公司之間日益加強的合作最終推動了腦機介面市場的成長。
預計北美在預測期內將實現盈利成長。北美國家正積極進行腦機介面(BCI)技術的研發和臨床試驗。高昂的研發費用、最先進的基礎設施建設以及最尖端科技的有效利用是推動北美地區腦機介面市場擴張的主要原因。帕金森氏症、亨廷頓氏症和阿茲海默症神經系統疾病的發生率預計也將推動市場擴張。此外,隨著腦機介面的改進等最尖端科技的發展,逼真遊戲的受歡迎程度和需求預計將會增加。這將加速 BCI 技術在美國、加拿大和其他北美國家的採用。
According to Stratistics MRC, the Global Brain Computer Interface Market is accounted for $2.07 billion in 2023 and is expected to reach $7.23 billion by 2030 growing at a CAGR of 19.5% during the forecast period. A brain-computer interface (BCI), also referred to as a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), brain-machine interface (BMI), or brain-machine interface, is a platform that allows for direct brain-to-external device communication. In order to record the electrical impulses sent by the human brain, brain machine interface systems integrate brain imaging methods such as magnetoencephalography (MEG), functional magnetic resonance imaging (fMRI), electrocorticography (ECOG), and electroencephalography (EEG).
According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years.
The rising incidence of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, is significantly impacting the Brain-Computer Interface (BCI) market. These disorders cause a gradual decline in cognitive and motor functions, making it challenging for individuals to communicate or interact with their environment effectively. As the prevalence of neurodegenerative disorders continues to grow globally due to ageing populations and improved diagnostics, the demand for advanced BCIs is on the rise. Furthermore, innovations in BCI technology, including enhanced signal processing, machine learning algorithms, and miniaturised implants, are crucial in addressing the specific needs of individuals affected by neurodegenerative disorders, fuelling the growth and evolution of the BCI market to cater to this growing patient population.
The high cost associated with Brain-Computer Interface (BCI) technology serves as a significant restraint in the BCI market. The intricate research, development, and manufacturing processes involved contribute to the elevated expenses. These costs are then passed on to consumers, limiting widespread adoption and accessibility, especially for individuals with limited financial resources. Insurance coverage often falls short of adequately supporting BCI acquisitions. As a result, many potential users are unable to afford this cutting-edge technology, impeding its broader adoption and hindering the market's potential growth.
The rapid expansion and advancement of healthcare facilities present a substantial opportunity for the Brain-Computer Interface (BCI) market. With an increasing focus on precision medicine and personalised healthcare, BCIs offer an innovative avenue for improved diagnosis, treatment, and patient care. The integration of BCIs within healthcare systems allows for real-time monitoring of neural activities, facilitating early detection and intervention in various neurological disorders. Moreover, the collaboration between healthcare facilities and BCI developers enables the customization of BCI solutions to align with specific medical requirements. The symbiotic relationship between healthcare and BCIs holds immense potential to transform patient outcomes and drive the continued growth and integration of BCIs into mainstream healthcare practices.
The dearth of skilled professionals poses a significant threat to the Brain-Computer Interface (BCI) market. Developing and operating BCIs requires expertise in multiple disciplines, such as neuroscience, engineering, signal processing, and machine learning. However, there's a shortage of professionals proficient in these areas. This scarcity limits the pace of research, innovation, and effective implementation of BCI technology. Additionally, the intricate nature of BCIs necessitates specialised training, making it challenging for healthcare providers and technicians to adopt and utilise these technologies optimally. Thus, it is hampering market growth.
The COVID-19-induced recession is having a significant impact on industries all around the world; however, the technology industry was somewhat less affected by the crisis than the rest of the economy was. Also, the pandemic has caused a recession in the economy that has forced various enterprises across the globe to dramatically and rapidly shift their operations. There have been more developments that support the spread of cutting-edge technology like artificial intelligence and the internet of things. Moreover, due to less human-to-machine contact during the COVID-19 pandemic, organisations that had already implemented brain-computer interfaces were able to quickly adapt to the new virus variant, meeting business requirements that were brought about by developments in the healthcare sector. Brain-computer interfaces assist firms in managing the ongoing pandemic and continuing to operate profitably.
The Invasive brain computer interface segment is estimated to hold the largest share. It involves implanting electrodes directly into the brain to establish a precise and high-fidelity neural interface. This approach provides unparalleled accuracy and data resolution, making it ideal for complex applications such as neuroprosthetics and restoring motor functions. Moreover, the invasive BCI segment continues to evolve with advancements in surgical techniques, materials, and signal processing algorithms. Ongoing research and innovations in this domain hold immense promise for enhancing the capabilities and expanding the potential applications of invasive BCIs. Hence, there is an increasing demand for segment growth.
The Hardware segment is anticipated to have lucrative growth during the forecast period. The hardware segment of the Brain-Computer Interface (BCI) market encompasses the essential physical components needed for BCI systems to function effectively. This includes electrodes, sensors, amplifiers, signal processing units, and output devices. Electrodes play a critical role in capturing neural signals, while sensors ensure accurate data acquisition. Also, amplifiers strengthen and process these signals for analysis. The signal processing units interpret the neural data, and output devices convey the feedback or actions generated by the BCI system. Moreover, continuous advancements in hardware technology, miniaturisation, and material improvements are enhancing the efficiency, comfort, and durability of BCIs, contributing to the overall growth and adoption of BCIs across various applications and industries.
Asia Pacific commanded the largest market share during the extrapolated period. The Asia-Pacific region's brain computer interface market is expanding as a result of increasing government funding and considerable research being done to find treatments for diseases and damage to the brain. Additionally, the availability of affordable manufacturing locations and alluring tax policies have enticed foreign corporations to invest in this lucrative sector in Asian nations. This has significantly encouraged the industry for brain-computer interfaces to expand in this area. Furthermore, the rising number of collaborations among BCI market players across Asia Pacific region is ultimately evolving the growth of the brain computer interface market.
North America is expected to witness profitable growth over the projection period. R&D and clinical trial investigations for brain-computer interface (BCI) technologies are heavily pursued in North American countries. High R&D spending, the creation of cutting-edge infrastructure, and the effective use of cutting-edge technology are a few of the primary reasons fostering the expansion of the brain-computer interface market in the North American region. The incidence of neurological disorders like Parkinson's, Huntington's disease, and Alzheimer's is also projected to spur market expansion. Additionally, as cutting-edge technology like improved brain-computer interfaces develops, the popularity and demand for realistic gaming are projected to rise. This will hasten the adoption of BCI technologies in the United States, Canada, and other North American nations.
Some of the key players in the Brain Computer Interface Market include: Mind Technologies Inc., Compumedics, Ltd., Covidien, PLC, Natus Medical, Inc., Integra Life Sciences Corporation, Nihon Kohden Corporation, CAS Medical Systems, Advanced Brain Monitoring Inc., G.Tec Medical Engineering Gmbh, Integra Lifesciences Corporation, Brain Products Gmbh, Neurosky, Neuroelectrics, Nirx Medical Technologies, LLC, Ripple Neuro, Cadwell Industries, Cortech Solutions Inc, Natus Medical Incorporated, Emotiv Inc. and Medtronic.
In May 2023, Neuralink secured elusive FDA approval to initiate human trials of their brain-computer interface technology.
In January 2023, MicroCloud Hologram Inc., a provider of Hologram Digital Twins Technology, announced the release of their holographic BCI data collecting system. The holographic BCI data acquisition system from HOLO combines BCI and holographic technology, allowing the two technologies to complement one another. Holographic technology can be used to provide more realistic, rich, and stimulating contextual feedback for a more immersive user experience in BCI systems.